A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe Biden on lowering prescription drug costs in posts online that suggest President Donald Trump has canceled the $35 insulin co-pay cap for certain Medicare programs.
A satirical X post saying the three major insulin manufacturers in the United States had announced 2,000%-3,000% price increases after President Donald Trump rescinded a 2022 executive order on prescription drug prices has been shared online as authentic.
The parents of Elizabeth Rose Struhs, who died in 2022, were part of a small religious sect in Australia that believed that medical care went against their faith.
After Natalie Cochran poisoned her husband, she told friends she would let him "sleep it off" instead of taking him to the hospital, prosecutors said.
“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, seriously poorer,” Steven Bechloss—author of the Substack, America, America — posted to the Bluesky social media platform.
Novo Nordisk to cap insulin prices in Minnesota settlement
President Donald Trump voided an executive order signed by former-President Joe Biden aimed at lowering prescription drug prices.
Researchers explore the impact of exercise on the short-term regulation of insulin pathways in brain circuits.
Minnesota Attorney General Keith Ellison on Monday will share a major development in his lawsuit against three of the biggest insulin manufacturers. Ellison first accused the companies of deceptive pricing back in 2018. Now, Minnesotans are paying less for insulin — depending on where they’re buying it from.
ST. PAUL, Minn. – All Minnesotans, whether they have insurance or not, will be able to buy insulin products for $35 a month for the next five years.
Attorney General Keith Ellison announced a settlement with Novo Nordisk that let's Minnesotans buy its insulin products for $35 per month.
The settlement resolves the Attorney General’s 2018 lawsuit alleging that Novo Nordisk deceptively priced its insulin.